-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LLVtZB0PyIA2ksK4NHHQueyZd9z/dJeCi3pQGCeyf//Lm4HE5wc0FdItwou3UuKP 1uf5ZYoVIfeR9JQPerxO8A== 0000920148-03-000039.txt : 20030214 0000920148-03-000039.hdr.sgml : 20030214 20030214180825 ACCESSION NUMBER: 0000920148-03-000039 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20021231 FILED AS OF DATE: 20030214 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: MAC MAHON THOMAS P CENTRAL INDEX KEY: 0001168580 RELATIONSHIP: OFFICER FILING VALUES: FORM TYPE: 5 BUSINESS ADDRESS: STREET 1: 430 S SPRING STREET CITY: BURLINGTON STATE: NC ZIP: 27215 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 03569234 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 5 1 fm5tpm2002.txt 123102 FORM 5 ------------------------------ OMB APPROVAL ------------------------------ OMB Number 3235-0362 Expires: January 31, 2005 Estimated average burden hours per response ....... 1.0 ------------------------------ U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 5 ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 [_] Check box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). [_] Form 3 Holdings Reported [_] Form 4 Transactions Reported - -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* Mac Mahon, Thomas P. - -------------------------------------------------------------------------------- (Last) (First) (Middle) c/o Laboratory Corporation of America Holdings, 430 South Spring Street - -------------------------------------------------------------------------------- (Street) Burlington, North Carolina 27215 - -------------------------------------------------------------------------------- (City) (State) (Zip) - -------------------------------------------------------------------------------- 2. Issuer Name and Ticker or Trading Symbol Laboratory Corporation of America Holdings ("LH") - -------------------------------------------------------------------------------- 3. IRS Identification Number of Reporting Person, if an Entity (Voluntary) - -------------------------------------------------------------------------------- 4. Statement for Month/Year December 31, 2002 - -------------------------------------------------------------------------------- 5. If Amendment, Date of Original (Month/Year) - -------------------------------------------------------------------------------- 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) [X] Director [_] 10% Owner [X] Officer (give title below) [_] Other (specify below) Chairman of the Board, President & Chief Executive Officer ---------------------------------------------------------- - -------------------------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check applicable line) [X] Form Filed by One Reporting Person [_] Form Filed by More than One Reporting Person - -------------------------------------------------------------------------------- ================================================================================ Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ================================================================================
5. 6. 4. Amount of Owner- Securities Acquired (A) Securities ship 2A. or Disposed of (D) Beneficially Form: 7. 2. Deemed (Instr. 3, 4 and 5) Owned at End Direct Nature of Transaction Execution 3. ------------------------- of Issuer's (D) or Indirect 1. Date Date, if Transaction (A) Fiscal Year Indirect Beneficial Title of Security (Month/Day any (Month/ Code Amount or Price (Instr. 3 (I) Ownership (Instr. 3) Year) Day/Year) (Instr. 8) (D) and 4) (Instr.4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 1/7/02 A 68,200 A D - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 2/14/02 A 101,000 A 684,612 (1) D - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
(1) Amount shown reflects a 2-for-1 stock split effective on May 10, 2002. (Over) SEC 2270 (6-02) FORM 5 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================
5. Number of 6. 3A. Derivative Date 2. 3. Deemed Securities Exercisable and 1. Conversion Trans- Execution Acquired (A) or Expiration Date Title of or Exercise action Date, if 4. Disposed of (D) (Month/Day/Year) Derivative Price of Date any Transaction (Instr. 3, 4 and 5) ----------------------- Security Derivative (Month/ (Month/ Code ------------------- Date Expiration (Instr. 3) Security Day/Year) Day/Year) (Instr.8) (A) (D) Exercisable Date - ------------------------------------------------------------------------------------------------------------------------------------ Non-Qualified Stock Option (2) $78.68 1/7/02 A 101,500 (3) 1/7/12 - ------------------------------------------------------------------------------------------------------------------------------------ Non-Qualified Stock Option (4) $87.06 2/14/02 A 144,200 (5) 2/14/12 - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ ==================================================================================================================================== 7. Title and Amount 9. of Underlying Number of 10. Securities Derivative Ownership 11. (Instr. 3 and 4) 8. Securities of Derivative Nature of - ---------------------------- Price of Beneficially Security: Indirect Amount or Derivative Owned at End Direct (D) or Beneficial Number of Security of Year Indirect (I) Ownership Title Shares (Instr. 5) (Instr. 4) (Instr. 4) (Instr. 4) - ---------------------------------------------------------------------------------------------------------------- Common Stock 101,500 $78.68 203,000 (6) D - ---------------------------------------------------------------------------------------------------------------- Common Stock 144,200 $87.06 288,400 (6) D - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- ================================================================================================================
Explanation of Responses: (2) Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2000 Stock Incentive Plan. (3) The option vests in three equal annual installments beginning on January 7, 2003. (4) Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2000 Stock Incentive Plan. (5) The option vests in three equal annual installments beginning on February 14, 2003. (6) Amount shown reflects a 2-for-1 stock split effective on May 10, 2002. /s/ Bradford T. Smith February 14, 2003 - --------------------------------------------- ----------------------- **Signature of Reporting Person Date Bradford T. Smith, Attorney-in-Fact for Thomas P. Mac Mahon Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one Reporting Person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. Page 2 -----END PRIVACY-ENHANCED MESSAGE-----